• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
Nairametrics
Home Economy Socio Economic

US Mission recognises Nigerian doctor who helped develop COVID-19 vaccine

Adeyemi Adebayo by Adeyemi Adebayo
November 23, 2020
in Socio Economic
US Mission recognises Nigerian doctor who helped develop COVID-19 vaccine
Share on FacebookShare on TwitterShare on Linkedin

The U.S. Mission Nigeria has recognised a Nigerian doctor, Dr. Onyema Ogbuagu for his excellent work in the field of medicine.

Commenting on Dr. Ogbuagu’s contribution to the breakthrough in Pfizer’s COVID-19 vaccine, the Mission in a Twitter message submitted that, “Nigerians contribute to the world in so many ways. Our hats off to Dr. Onyema Ogbuagu at Yale who helped develop a covid-19 vaccine.”

Nigerians contribute to the world in so many ways. Our hats off to Dr. Onyema Ogbuagbu at Yale who helped develop a COVID-19 vaccine! pic.twitter.com/DYFWHlJSFM

— U.S. Mission Nigeria (@USinNigeria) November 23, 2020

MoreStories

Tinubunomics Not Working: SME’s groan over rising cost of doing business

September 21, 2025
IMF Spring Meetings: Edun, Cardoso declare Nigeria’s reforms are winning global endorsement

IMF Spring Meetings: Edun, Cardoso declare Nigeria’s reforms are winning global endorsement

April 26, 2025

News had broken a few days earlier, following Dr. Ogbuagu’s interview with ABC news, regarding his contribution to the development of Pfizer’s first effective COVID-19 vaccine in the United States. He confirmed that he had been involved in the trials of the vaccines by Pfizer.

What you should know

Dr Ogbuagu is an Associate Professor of Medicine and Infectious Disease at Yale School of Medicine. He is the Director of the HIV Clinical Trials programme of the Yale AIDS Programme, Section of Infectious Diseases of the Yale School of Medicine.

Dr. Ogbuagu graduated with a degree in Medicine from the University of Calabar in 2003, then migrated to the US and rose to become Associate Professor of Medicine and Infectious Disease Specialist at Yale University.

Ogbuagbu’s responsibilities at Yale include educating and training medical students, residents and infectious diseases fellows in various capacities in inpatient and outpatient settings, and through structured course work and other teaching sessions.

According to his profile on the website of Yale School of Medicine, in response to the COVID-19 pandemic, he was the Yale principal investigator on multiple investigational therapeutic and preventative clinical trials for COVID-19, including remdesivir (now FDA approved), leronlimab and remdesivir and tocilizumab combination therapy as well as the Pfizer/BioNTech Vaccine trial.

Dr. Ogbuagu is the son of a former Vice-Chancellor of Abia State University, Prof Stella Ogbuagu. He also has a twin brother who is an engineer.


Add Nairametrics on Google News
Follow us for Breaking News and Market Intelligence.
Tags: Onyema OgbuaguU.S. Mission Nigeria
Adeyemi Adebayo

Adeyemi Adebayo

Adeyemi holds a PhD in Accounting Sciences. He has worked in the Educational Sector and as an Independent Consultant.

Next Post
AstraZeneca suspends COVID-19 vaccine final stage trial over safety concerns, COVID-19: J&J starts vaccine trials on humans after success on monkeys

COVID-19: AstraZeneca vaccine could be 90% effective against the virus

Comments 2

  1. Chris Ede says:
    November 25, 2020 at 10:58 pm

    Very uplifting and encouraging news and should make all Nigerians and the country proud. To the young Dr Ogbuagu, many thanks. God bless you and more grease to your elbow.

    Reply
  2. Rufina Okoronkwo says:
    December 1, 2020 at 6:27 pm

    Good job DR Ogbuagu. Thank you so much for making our great country Nigeria greater.All Nigerians are proud of you.Thanks again.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

rabafast
rabafast

nairametrics





DUNS

Follow us on social media:

  • HOME
  • ABOUT NAIRAMETRICS
  • CONTACT US
  • DISCLAIMER
  • ADs DISCLAIMER
  • COPYRIGHT INFRINGEMENT

© 2026 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Social Media Auto Publish Powered By : XYZScripts.com
No Result
View All Result
  • Home
  • Exclusives
    • Recapitalization
      • Access Holdings Offer
      • Fidelity Bank Offer
      • GTCO Offer
      • Zenith Bank Offer
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
    • Nairalytics
  • Economy
    • Business News
    • Budget
    • Public Debt
    • Tax
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Company Results
      • Dividends
      • Public Offer & Right Issues
      • Stock Market News
    • Fixed Income
    • Funds Management
    • Securities
  • Sectors
    • Agriculture
    • Aviation
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Renewables & Sustainability
    • Tech News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Market Views
    • Op-Eds
    • Research Analysis
  • Login
  • Sign Up

© 2026 Nairametrics